www.HomelandDefenseStocks.com, a global investment research portal for the Homeland Defense and Security Sector reports on markets following the recent discovery of an artillery shell found in Iraq rigged with sarin nerve gas. The market for both biological and chemical detection technologies is strong as ongoing terrorist activities create an urgent demand for detection/protection solutions, and treatment counter measures especially as Project Bioshield, a $5.6 billion initiative is back in front of the Senate. Other strong indicators for companies in the sector include the recent Army contract awarded to Science Applications International Corp. to provide an integrated chemical, biological, radiological and nuclear protection (CBRN) capability at two hundred Department of Defense (DoD) installations and facilities worldwide. The cumulative value of the contract is $390 million.
Featured Companies in the sector, Markland Technologies, Inc. (OTCBB: MRKL) www.marklandtech.com. is positioned in the chemical detection market and Aethlon Medical, Inc. (OTCBB: AEMD) www.AethlonMedical.com which is developing pathogen filtration devices to treat infectious agents used in biological warfare and terrorism. Other companies in the news that will potentially benefit from Project Bioshield include Hollis-Eden Pharmaceuticals, Inc. and VaxGen, Inc.
